The estimated Net Worth of Alan Sebulsky is at least $7.26 Milhão dollars as of 9 March 2012. Alan Sebulsky owns over 31,166 units of Jazz Pharmaceuticals plc stock worth over $5,714,341 and over the last 17 years Alan sold JAZZ stock worth over $1,544,587.
Alan has made over 5 trades of the Jazz Pharmaceuticals plc stock since 2007, according to the Form 4 filled with the SEC. Most recently Alan sold 31,166 units of JAZZ stock worth $1,544,587 on 9 March 2012.
The largest trade Alan's ever made was exercising 46,536 units of Jazz Pharmaceuticals plc stock on 14 December 2011 worth over $657,088. On average, Alan trades about 9,180 units every 116 days since 2007. As of 9 March 2012 Alan still owns at least 54,355 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Alan Sebulsky stock trades at the bottom of the page.
Alan's mailing address filed with the SEC is C/O JAZZ PHARMACEUTICALS, INC., 3180 PORTER DRIVE, PALO ALTO, CA, 94304.
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright, eJp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: